Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Total Environ ; 710: 136375, 2020 Mar 25.
Article in English | MEDLINE | ID: mdl-31923693

ABSTRACT

Direct membrane filtration has shown great potential in wastewater treatment and resource recovery in terms of its superior treated water quality, efficient nutrient recovery, and sustainable operation, especially under some scenarios where biological treatment is not feasible. This paper aims to give a comprehensive review of the state-of-the-art of direct membrane filtration processes (including pressure-driven, osmotic-driven, thermal-driven, and electrical-driven) in treating different types of wastewater for water reclamation and resource recovery. The factors influencing membrane performance and treatment efficiency in these direct membrane filtration processes are well illustrated, in which membrane fouling was identified as the main challenge. The strategies for improving direct membrane filtration performance, such as physical and chemical cleaning techniques and pretreatment of feed water, are highlighted. Towards scaling-up and long-term operation of direct membrane filtration for effective wastewater reclamation and resource recovery, the challenges are emphasized and the prospects are discussed.

2.
Int Immunopharmacol ; 7(9): 1179-84, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17630196

ABSTRACT

DDT is used for pest control, causing health and environmental hazards in some parts of the world. The goal of this study was to assess whether immunization against a toxic compound could reduce the toxicant uptake of an organism, specifically to develop a DDT immunization that promotes the production of specific antibodies and assess whether it reduces DDT levels in the bodies of mice that are exposed to DDT by intake. BALB/c mice were immunized with DDT-keyhole limpet hemocyanine (DDT-KLH) conjugate (n=10) or unconjugated KLH (n=10), which was used as a control. After the immunization specific DDT antibodies in the mouse serum were determined by ELISA and then the mice were fed chow containing 40 mg/kg of DDT for 45 days. Finally, the concentration of DDT and its metabolites, DDE and DDD, in various tissues was measured by gas chromatography. Specific DDT antibody levels were significantly higher in the DDT immunized group than in the control group. DDT, DDE and DDD levels in adipose tissue, blood, brain and spleen were significantly reduced in the DDT immunized animals relative to control animals. However, DDT and DDD levels were higher in the liver compared to the control group. The findings indicate that the DDT immunization reduces the total uptake of DDT in animal tissues, which is reflected by the lower levels in adipose tissue, blood, brain and spleen. The elevated levels in liver suggest that DDT-antibody complexes in mouse serum are delivered to the liver.


Subject(s)
Antibodies/blood , DDT/antagonists & inhibitors , DDT/immunology , Immunization , Animals , DDT/pharmacokinetics , Female , Mice , Mice, Inbred BALB C
3.
Arthritis Res Ther ; 8(6): R178, 2006.
Article in English | MEDLINE | ID: mdl-17129378

ABSTRACT

Juvenile idiopathic arthritis (JIA) is a heterogeneous autoimmune disease characterized by chronic joint inflammation. Knowing which antigens drive the autoreactive T-cell response in JIA is crucial for the understanding of disease pathogenesis and additionally may provide targets for antigen-specific immune therapy. In this study, we tested 9 self-peptides derived from joint-related autoantigens for T-cell recognition (T-cell proliferative responses and cytokine production) in 36 JIA patients and 15 healthy controls. Positive T-cell proliferative responses (stimulation index > or =2) to one or more peptides were detected in peripheral blood mononuclear cells (PBMC) of 69% of JIA patients irrespective of major histocompatibility complex (MHC) genotype. The peptides derived from aggrecan, fibrillin, and matrix metalloproteinase (MMP)-3 yielded the highest frequency of T-cell proliferative responses in JIA patients. In both the oligoarticular and polyarticular subtypes of JIA, the aggrecan peptide induced T-cell proliferative responses that were inversely related with disease duration. The fibrillin peptide, to our knowledge, is the first identified autoantigen that is primarily recognized in polyarticular JIA patients. Finally, the epitope derived from MMP-3 elicited immune responses in both subtypes of JIA and in healthy controls. Cytokine production in short-term peptide-specific T-cell lines revealed production of interferon-gamma (aggrecan/MMP-3) and interleukin (IL)-17 (aggrecan) and inhibition of IL-10 production (aggrecan). Here, we have identified a triplet of self-epitopes, each with distinct patterns of T-cell recognition in JIA patients. Additional experiments need to be performed to explore their qualities and role in disease pathogenesis in further detail.


Subject(s)
Aggrecans/immunology , Arthritis, Juvenile/immunology , Autoantigens/immunology , Matrix Metalloproteinase 3/immunology , Microfilament Proteins/immunology , T-Lymphocytes/immunology , Age of Onset , Autoimmunity , Child , Child, Preschool , Cytokines/biosynthesis , Cytokines/immunology , Epitopes, T-Lymphocyte/immunology , Female , Fibrillins , Flow Cytometry , Humans , Male
4.
Biol Pharm Bull ; 28(6): 1038-42, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15930741

ABSTRACT

The goal of this study was to investigate an intranasal cocaine vaccine containing the mucosal adjuvant macrogol-6-glycerol capylocaprate (RhinoVax). Cocaine-KLH conjugate was prepared and administered in two formulations. Ten mice were immunised intranasally using RhinoVax as adjuvant and ten subcutaneously using aluminium hydroxide as an adjuvant. A negative control group (n=10) received unconjugated KLH with RhinoVax intranasally. Specific cocaine antibodies in serum were measured following primary and booster immunisation. Relative antibody responses in serum indicated that the immunisation was successful. Animals were then challenged with cocaine either intranasally or intraperitoneally with subsequent measurement of drug distribution into the serum, brain and olfactory bulb. The cocaine-immunised groups revealed significantly lower cocaine levels in the brain compared to the negative control group. The inhibition of cocaine distribution to the brain in the intranasal immunised group was comparable to that of the subcutaneous immunised group. This was unexpected because the cocaine specific antibody levels in serum were fivefold lower in the intranasal immunised group. However, the presence of mucosal cocaine specific antibodies after intranasal immunisation could play an important role in hindering direct access of cocaine into the brain via the olfactory bulb.


Subject(s)
Antibodies/metabolism , Cocaine/metabolism , Glycerides/administration & dosage , Immunization/methods , Administration, Intranasal , Animals , Brain/metabolism , Cocaine/administration & dosage , Cocaine/antagonists & inhibitors , Female , Glycerides/metabolism , Mice , Mice, Inbred BALB C
SELECTION OF CITATIONS
SEARCH DETAIL
...